Table 2 AMD-associated genes located in novel loci that did not reach genome-wide significance in previous GWAS studies2.
Gene | Chr | Gene Expression Prediction | Strongest effect tissuea | Model Information in Strongest Effect Tissue | |||
---|---|---|---|---|---|---|---|
Predictable Tissues | AMD associated (FDR < 0.001) | Mean effect size (SD) | Variants in model | AMD associated (GWAS P-value < 1 × 10-04)b | |||
C1orf21 | 1 | 15 | 1 | −0.028 | Liver | 34 | 3 |
CD55 | 1 | 17 | 3 | −0.016 (0.003) | Esophagus Muscularis | 59 | 5 |
CR2 | 1 | 3 | 1 | −0.013 | Muscle Skeletal | 40 | 6 |
NOSTRIN | 2 | 18 | 1 | −0.015 | Esophagus Mucosa | 44 | 0 |
PPIL3 | 2 | 27 | 16 | 0.037 (0.004) | Adipose Subcutaneous | 37 | 24 |
NDUFB3 | 2 | 6 | 4 | 0.005 (0.001) | Adipose Subcutaneous | 12 | 8 |
ADAM19 | 5 | 21 | 12 | −0.013 (0.006) | Adipose Subcutaneous | 25 | 8 |
IP6K3 | 6 | 17 | 1 | 0.019 | Cells Transformed fibroblasts | 22 | 1 |
ZFP37 | 9 | 10 | 1 | −0.017 | Adipose Subcutaneous | 53 | 0 |
RP11.777F6.3 | 11 | 2 | 1 | 0.007 | Testis | 5 | 2 |
CEP57 | 11 | 23 | 3 | −0.02 (0.005) | Skin Not Sun Exposed Suprapubic | 48 | 0 |
AP001877.1 | 11 | 24 | 8 | −0.016 (0.006) | Nerve Tibial | 50 | 0 |
RIN3 | 14 | 13 | 1 | 0.018 | Colon Sigmoid | 24 | 2 |
ULK3 | 15 | 17 | 1 | −0.01 | Lung | 10 | 4 |
USP7 | 16 | 3 | 1 | 0.014 | Muscle Skeletal | 55 | 1 |
FUT2 | 19 | 11 | 1 | −0.009 | Lung | 23 | 0 |
MAMSTR | 19 | 9 | 1 | 0.007 | Adrenal Gland | 13 | 0 |
LILRA3 | 19 | 23 | 1 | −0.016 | Colon Sigmoid | 15 | 2 |